Vassoo thought his white patches — smaller than a 10p piece – were sun damage Eventually he was referred to a dermatologist who diagnosed vitiligo Vitiligo is one of the most common autoimmune skin diseases Now a new transplant restores colour to skin damaged by vitiligo Vassoo Devan Arian, a retired NHS nurse, was horrified when a...
Category: <span>Pharmaceutical Updates</span>
Post
New snakebite treatment makes major advance
A University of Arizona researcher developing a therapy to prevent or delay the dangerous results of rattlesnake and other venomous snakebites in humans has shown that a combination of carbon monoxide and iron inhibits snake venom’s effects for up to an hour in animals, a major advance in bringing the treatment to market. Snake...
Post
Long-lasting flu vaccine may only take one jab per decade
A new long-lasting flu vaccine could cut back the frequency of the jab to once every 10 years Getting a flu shot is an unpleasant annual routine for many people, but the virus’ tendency to constantly evolve makes it a necessity. Now researchers from Cornell University have developed a new vaccine that acts faster,...
Post
Glowing Molecular Sensor Helps Spot New Useful Antibiotics
Microorganisms are natural factories for all sorts of biomolecules, and some of them produce antibiotics that can be very useful in medical practice. This is not a newly discovered fact, but because each microorganism produces its own set of molecules and the rate of production is not very high, it’s been difficult to use this...
Post
Out-of-pocket costs often keep pricey new cholesterol drugs out of reach, study finds
Access to powerful new cholesterol-lowering drugs is so tightly controlled and patients’ out-of-pocket costs are so high that fewer than a third of people whose doctors prescribe the drugs get them, a new study found. While highly effective, the new drugs cost as much as $14,000 annually, leading some insurers and pharmacy benefit managers to require doctors...
Post
Researchers help develop new antifungal drug
Aspergillosis. University of Liverpool researchers, working with F2G Limited (Eccles, Manchester), have developed a new antifungal drug to help in the treatment of life threatening invasive fungal infections such as invasive aspergillosis. Invasive fungal infections are common and often lethal. Despite optimal medical care mortality is 20-30% at six weeks and dramatically rises to 80-100%...
Post
Teva hit with surprise Copaxone generic, Mylan celebrates
Dive Brief: Just days after the Food and Drug Administration issued its stance on approving complex generics more quickly, the agency did just that, giving the go-ahead to Mylan N.V.’s copycat version of the 40 mg/mL dose of Copaxone. Teva Pharmaceuticals Industries Ltd. has been staving off competition to its best-selling drug for years; first through legal...
Post
Arthritis pill: Daily intake of new treatment halts disabling bone loss and damage
A DAILY pill which halts the disabling bone loss caused by osteoarthritis is being hailed as a new dawn in the treatment of the disease. The new drug has excited scientists after trials showed that after just six months it reduced bone damage around knee joints and also maintained cartilage thickness. It is the first...
Post
Diabetes drug helps obese people lose 12lbs over 3 months and could spell the end of costly gastric bypasses, study finds
The prescription-only drug helps to slow down the stomach from emptying American experts believe the drug could steer fat adults onto the right path Surgeons claim gastric bypasses are the most effective treatments for obesity A type 2 diabetes drug may stop thousands of obese people from needing gastric bypasses, scientists claim. US researchers at...
Post
A New Approach to Cancer Drug Discovery
Scientists at The Scripps Research Institute (TSRI) have developed and demonstrated a promising new strategy for the discovery of novel anti-cancer therapies. The TSRI scientists, collaborating with scientists at Pfizer, used their new approach to find small-molecule inhibitors of a protein that is important for the growth of non-small-cell lung cancers (NSCLCs). These cancers represent...